JP2009508822A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009508822A5 JP2009508822A5 JP2008530342A JP2008530342A JP2009508822A5 JP 2009508822 A5 JP2009508822 A5 JP 2009508822A5 JP 2008530342 A JP2008530342 A JP 2008530342A JP 2008530342 A JP2008530342 A JP 2008530342A JP 2009508822 A5 JP2009508822 A5 JP 2009508822A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- functional
- functional factor
- plasma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05020409 | 2005-09-19 | ||
| PCT/EP2006/005631 WO2007038995A1 (en) | 2005-09-19 | 2006-06-13 | Factor h for the treatment of chronic nephropathies and production thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012116143A Division JP2012184251A (ja) | 2005-09-19 | 2012-05-22 | 尿細管間質性線維症または進行性腎不全を処置するための機能性ｈ因子の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009508822A JP2009508822A (ja) | 2009-03-05 |
| JP2009508822A5 true JP2009508822A5 (https=) | 2009-06-25 |
Family
ID=36001069
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008530342A Pending JP2009508822A (ja) | 2005-09-19 | 2006-06-13 | 慢性腎症の処置のためのｈ因子およびその製造 |
| JP2012116143A Pending JP2012184251A (ja) | 2005-09-19 | 2012-05-22 | 尿細管間質性線維症または進行性腎不全を処置するための機能性ｈ因子の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012116143A Pending JP2012184251A (ja) | 2005-09-19 | 2012-05-22 | 尿細管間質性線維症または進行性腎不全を処置するための機能性ｈ因子の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20090118163A1 (https=) |
| EP (1) | EP1928483B1 (https=) |
| JP (2) | JP2009508822A (https=) |
| KR (1) | KR20080048034A (https=) |
| AU (1) | AU2006299293B2 (https=) |
| CA (1) | CA2627264A1 (https=) |
| WO (1) | WO2007038995A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2894145B1 (fr) * | 2005-12-07 | 2008-10-17 | Lab Francais Du Fractionnement | Utilisation de facteur h du complement a titre de medicament |
| ES2595059T3 (es) * | 2007-03-20 | 2016-12-27 | Csl Behring Gmbh | Métodos para la producción a escala industrial de preparados terapéuticos del Factor H del complemento a partir de plasma humano |
| LT2894165T (lt) | 2008-11-10 | 2023-03-10 | Alexion Pharmaceuticals, Inc. | Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui |
| GB0904427D0 (en) | 2009-03-13 | 2009-04-29 | Lachmann Peter | Treatment of diseases related to hyperactivity of the complement system |
| US8304524B2 (en) | 2009-07-23 | 2012-11-06 | Baxter International Inc. | Manufacture of factor H (FH) and FH-derivatives from plasma |
| FR2952640B1 (fr) | 2009-11-16 | 2012-12-07 | Lab Francais Du Fractionnement | Procede de fabrication d'une preparation de facteur h |
| FR2952539B1 (fr) | 2009-11-16 | 2012-01-13 | Lab Francais Du Fractionnement | Preparation d'un concentre de facteur h |
| GB0922659D0 (en) | 2009-12-24 | 2010-02-10 | Univ Edinburgh | Factor H |
| WO2011150284A2 (en) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| US9295713B2 (en) | 2010-09-15 | 2016-03-29 | Celldex Therapeutics, Inc. | Treatment of chronic nephropathies using soluble complement receptor type I (sCR1) |
| RU2013121589A (ru) * | 2010-10-13 | 2014-11-20 | Октафарма Аг | Способ очистки фактора комплемента н |
| FR2981661B1 (fr) * | 2011-10-25 | 2015-06-19 | Lfb Biotechnologies | Procede de preparation du facteur h humain |
| FR2983212A1 (fr) | 2011-11-28 | 2013-05-31 | Lfb Biotechnologies | Aptameres anti-fh, procede pour leur obtention et utilisations |
| AU2013202965B2 (en) | 2013-03-15 | 2016-07-21 | Takeda Pharmaceutical Company Limited | Improved method for producing factor h from a plasma precipitation fraction |
| AU2013203048A1 (en) | 2013-03-15 | 2014-10-02 | Baxalta GmbH | Isolation of factor h from fraction i paste |
| AU2014306002B2 (en) | 2013-08-07 | 2017-05-25 | Alexion Pharmaceuticals, Inc. | Atypical hemolytic uremic syndrome (aHUS) biomarker proteins |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0742235B2 (ja) * | 1985-11-08 | 1995-05-10 | 三共株式会社 | 自己免疫性疾病の予防・治療剤 |
| US6492325B1 (en) * | 1998-05-22 | 2002-12-10 | Boys Town National Research Hospital | Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease |
| FR2894145B1 (fr) | 2005-12-07 | 2008-10-17 | Lab Francais Du Fractionnement | Utilisation de facteur h du complement a titre de medicament |
-
2006
- 2006-06-13 US US11/992,194 patent/US20090118163A1/en not_active Abandoned
- 2006-06-13 CA CA002627264A patent/CA2627264A1/en not_active Abandoned
- 2006-06-13 KR KR1020087006719A patent/KR20080048034A/ko not_active Ceased
- 2006-06-13 AU AU2006299293A patent/AU2006299293B2/en not_active Ceased
- 2006-06-13 JP JP2008530342A patent/JP2009508822A/ja active Pending
- 2006-06-13 WO PCT/EP2006/005631 patent/WO2007038995A1/en not_active Ceased
- 2006-06-13 EP EP06754313.2A patent/EP1928483B1/en not_active Not-in-force
-
2010
- 2010-11-01 US US12/916,807 patent/US10137165B2/en active Active
-
2012
- 2012-05-22 JP JP2012116143A patent/JP2012184251A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009508822A5 (https=) | ||
| JP2014506321A5 (https=) | ||
| MY199017A (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy | |
| JP2020002171A5 (https=) | ||
| WO2008064321A3 (en) | Methods of treating chronic inflammatory diseases using a gm-csf antagonist | |
| EA200800007A1 (ru) | Фармацевтические композиции на основе нейроактивного стероида и их применение | |
| MY178654A (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig protein scaffold for use in therapy | |
| WO2009045356A8 (en) | Microrna compositions in the treatment of vegf-mediated disorders | |
| JP2008538564A5 (https=) | ||
| WO2008050329A3 (en) | Novel sirnas and methods of use thereof | |
| MX2010004494A (es) | Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios. | |
| NO20072920L (no) | Kombinasjon av metylxantinforbindelser og steroider for a behandle kroniske respirasjonssykdommer | |
| JP2013521303A5 (https=) | ||
| Habas et al. | Common complications of hemodialysis: a clinical review | |
| WO2008024843A3 (en) | Combination therapy method for treating hepatitis c virus infection and pharmaceutical compositions for use therein | |
| EA201101643A1 (ru) | ВАРИАНТЫ ПРИМЕНЕНИЯ IL-1β АНТИТЕЛ И ИХ СВЯЗЫВАЮЩИХ ФРАГМЕНТОВ В СЕРДЕЧНО-СОСУДИСТОЙ СИСТЕМЕ | |
| US20180185446A1 (en) | Composition and method for inducing anti-apoptosis, survival or proliferation of a cell | |
| CN102186496A (zh) | 治疗肾功能紊乱的组合物和方法 | |
| NO20074084L (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse | |
| JP2012502103A5 (https=) | ||
| JP2015522603A5 (https=) | ||
| Lu et al. | Hydrogen sulfide alleviates peritoneal fibrosis via attenuating inflammation and TGF-β1 synthesis | |
| JP2014513121A5 (https=) | ||
| JP2013525310A5 (https=) | ||
| JP2013528649A5 (https=) |